dalbavancin
Brand names: Dalvance
Dalbavancin is an antibiotic medicine. It fights bacterial infections of the skin and tissues under the skin.
What it does
Dalbavancin treats acute bacterial skin and skin structure infections (ABSSSI).
Common side effects
Nausea, Headache, Diarrhea
Key warnings
Serious allergic reactions and skin reactions have been reported.
How It Works
Dalbavancin is a lipoglycopeptide antibiotic. It works by stopping bacteria from growing. This helps your body fight off the infection.
How to Take It
Dalbavancin is given through a vein (IV). It's usually given as a single dose. The IV infusion takes 30 minutes. The dose depends on your kidney function and weight.
Pregnancy & Breastfeeding
It is not known if dalbavancin will harm an unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if dalbavancin passes into breast milk. Talk to your doctor about the best way to feed your baby if you take this medicine.
Missed Dose
Since dalbavancin is usually given as a single dose, you don't have to worry about missed doses.
Storage
Store dalbavancin at room temperature (between 59ºF and 86ºF).
Side Effects (from patient reports)
Based on 623 FDA adverse event reports.
FDA Adverse Event Report Analysis
Detailed analysis of 911 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2014–2025.
Total Reports
911
Death-Related Reports
20
Hospitalization Reports
207
Top Indication
Product Used For Unknown Indication
Gender Distribution
Age Distribution
Most Reported Adverse Reactions (FAERS)
| # | Reaction | Reports |
|---|---|---|
| 1 | OFF LABEL USE | 138 |
| 2 | RASH | 93 |
| 3 | BACK PAIN | 55 |
| 4 | PRURITUS | 55 |
| 5 | DYSPNOEA | 53 |
| 6 | DRUG INEFFECTIVE | 51 |
| 7 | NAUSEA | 49 |
| 8 | HYPERSENSITIVITY | 45 |
| 9 | ERYTHEMA | 42 |
| 10 | VOMITING | 42 |
| 11 | URTICARIA | 37 |
| 12 | CHEST DISCOMFORT | 28 |
| 13 | INFUSION RELATED REACTION | 28 |
| 14 | DIARRHOEA | 26 |
| 15 | PYREXIA | 25 |
Reactions in Death Reports
Reactions in Hospitalization Reports
Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation
Serious Warnings
Serious allergic reactions and skin reactions have been reported. Tell your doctor right away if you have any signs of an allergic reaction. Rapid IV infusion can cause flushing, rash, itching, and back pain. Slowing the infusion may help.
Common Questions
What if I am allergic to glycopeptide antibiotics?
Can dalbavancin cause diarrhea?
Will dalbavancin affect my liver?
Can children take dalbavancin?
What if my kidneys don't work well?
Are there any drug interactions?
How will I receive dalbavancin?
How long does the infusion take?
What if I experience flushing or itching during the infusion?
What kind of bacteria does dalbavancin treat?
What are the common side effects of dalbavancin?
What drug class is dalbavancin?
Is dalbavancin safe during pregnancy?
Related Medications in Lipoglycopeptide Antibiotic
Other drugs grouped near dalbavancin — same-class peers and common alternatives.
amikacin
Amikin
Amikacin is an antibiotic medicine.
Compare with dalbavancin →
amoxicillin
Amoxil
Amoxicillin and Clavulanate Potassium is a combination medicine used to fight bacterial infections.
Compare with dalbavancin →
amoxicillin/clavulanate
Augmentin
Augmentin is a combination of two medicines, amoxicillin and clavulanate.
Compare with dalbavancin →
ampicillin/sulbactam
Unasyn
Unasyn is a combination of two antibiotics that fights bacteria in your body.
Compare with dalbavancin →
azithromycin
Zithromax, Z-Pack
Azithromycin is an antibiotic that fights bacteria.
Compare with dalbavancin →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
Why some drugs demand precise dosing and monitoring
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Related Health & Safety Data
🩺 Find a Doctor
Search prescribers for Lipoglycopeptide Antibiotic
🏨 Hospital Quality
CMS hospital ratings, safety scores & patient outcomes
💊 Supplement Data
NIH DSLD — check supplement ingredients & label claims
🍽️ Food Safety Alerts
FDA recalls, inspections & outbreak investigations
⚠️ Product Recalls
FDA, CPSC & NHTSA recall search
💉 Procedure Costs
Medicare procedure pricing for 9,297 procedures
Save on dalbavancin
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for dalbavancin
The FDA label for dalbavancin (sold under brand names such as Dalvance) classifies it as a prescription-only medication in the Lipoglycopeptide Antibiotic class. Dalbavancin treats acute bacterial skin and skin structure infections (ABSSSI). Official labeling lists 3 commonly reported side effects, including Nausea, Headache, Diarrhea.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 623 voluntary reports. Interaction data is drawn directly from FDA-approved prescribing information. Acquisition-cost data is surveyed weekly by CMS and updated as manufacturers report changes.
Report counts do not establish causation — a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice — always consult a licensed healthcare provider before starting, stopping, or changing any medication.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.
Last updated: October 6, 2025
Read our methodology — how this data is sourced, computed, and verified.
All federal data sources used on this page
- FDA Orange Book — approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed — NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) — post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm — standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files — federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database — current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages